@cancercolab

cancercolab has been a member of Linktree for 7 years and joined in February 2019. The social media accounts linked to from cancercolab are: • Instagram • YouTube • LinkedIn • Bluesky Besides social media accounts, cancercolab has populated their site with: • rethinking value in HTA • the case for a national precision oncology strategy | knowyourgenome.co • what you can do - POAM25 • HOME | knowyourgenome.co • partner activation kit #KNOWvember #POAM25 • rethinking how we define value in HTA (Chinese (simplified), Portuguese, Polish, Japanese, Korean, Spanish (Mexico), Swedish, Spanish) • rethinking how we define value in HTA (English, French (France and Canada), Catalan, Dutch, German, Greek, Italian, Portuguese (Brazil)) • patient engagement in HTA. report & recommendations • patient engagement in HTA. executive summary • S3E4 side effects may include... • S3.E3 fact vs feed. the health misinformation and disinformation problem • going viral. understanding viral vectors in cancer care • It'S #KNOWvember - this November know your genome! • behind the mciroscope. a conversation with pathologist Dr Carol Cheung • CBQA webinar precision diagnostics in oncology -who pays? • DISRUPT | The Patient Centricity Project • shaping tomorrow. the role of CAR-T in myeloma • COLAB.CONVERSATIONS S2E7. patient centricity. are we there yet? • A Letter To the Decision Makers Whose Decisions Can Impact The Lives Of Canadians Living with Cancer, To Those With The Power to Reshape The Landscape of Cancer Care in Canada • S2E4. shifting the conversation from cost to value • WEBINAR. IMPACT DRIVING PATIENT ADVOCACY SUSTAINABILITY • S2E3 creating space for women's health in healthcare • HERhealth. sarah's story experience of women with cancer • HERhealth. alvina's story. experience of women with cancer. • HERhealth. michelle's story. experience of women with cancer • the cancer collaborative: we're going to have to work together for a better cancer system in canada • why gender disparities in health matter • COLAB.CONVERSATIONS | colabcolab.conversations now available everywhere you like to watch/listen • colab.conversations now available on Spotify! • Opinion: COVID-19 is a blueprint for healthcare transformation • S1E4. a prescription for change. patient centered clinical trials and its impact for patients • S1.E3 unmute. amplifying the patient voice • CRISIS TO CATALYST. USING LESSONS LEARNED FROM COVID19 TO PRIORITIZE CANCER CARE IN CANADA. READ THE FULL PAPER • CRISIS TO CATALYST. HOW COVID19 TAUGHT US WE NEED TO DO BETTER FOR CANADIANS LIVING WITH CANCER. press release • PODCAST. COLAB.CONVERSATIONS • Opinion: CAR T-cell therapy delays jeopardize lives of Canadians with blood cancer • WATCH. looking back to move forward. learning from the implementation of CART in Canada • REGISTER. looking back to move forward. learnings from the implementation of CAR-T across Canada • WATCH. Evolution of CAR T cell therapies and future directions • REGISTER. evolution of CAR T-CELL therapies and future directions • #ASCO23 • FLIPPING THE SCRIPT. PUTTING THE U IN VALUE FRAMEWORKS • Project Orbis. Accelerating time to patient access? | colab • when to talk to your healthcare team about biomarker testing • why precision medicine matters • colorectal cancer canada survey results on molecular profiling in canada • the importance of biomarker testing • let’s talk about biomarkers - BRCA • tumour agnostic therapies are redefining cancer care • current biomarkers in cancer • understanding targeted therapies • understanding biomarkers • understanding precision medicine • precision medicine awareness month 2021 • what are biomarkers • what is precision medicine awareness month • colab.notebook ASCO20 EDITION • COVID 19 resources for the cancer community • colab statement on COVID 19 • data collection in the age of RWE. HTA engagement. a colab series • biosimilars can significantly reshape our healthcare systems • #Cracking the Cancer Code • if not now, when? • car-t. one year later • IEEPO recap- further thoughts on the promise of personalised medicines • it's that time of year. ASCO 2019 • the promise of personalized medicine • car-t. hype or hope • approval ≠ funding • the car-t revolution. shifting conversations. • new technology. old framework? • biosimilars. the european experience • being a change catalyst • managing innovation in oncology [mio] • about a community that created change • challenges & potential barriers to access